MedTrace Logo

Prevalence of Sarcopenia-Promoting Medicines in Patients With Sarcopenia and Falls

NCT07127692 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 323

Last updated 2025-08-22

No results posted yet for this study

Summary

Sarcopenia, characterised by the loss of muscle mass and function, is a common condition among the elderly and is often associated with increased risk of falls. Certain medications, such as glucocorticoids, statins, and some antipsychotics, may exacerbate sarcopenia, leading to a higher incidence of falls. This study aims to explore the prevalence of such medicines in patients diagnosed with sarcopenia who have experienced falls. Understanding the impact of these medications on sarcopenia and fall risk can inform clinical guidelines and improve patient outcomes.

Conditions

  • Sarcopenia in Elderly
  • Falls

Interventions

DIAGNOSTIC_TEST

Strength, Assistance with walking, Rise from a chair, Climb stairs, and Falls (SARC-F) questionnaire

Self-administered screening tool for sarcopenia

DIAGNOSTIC_TEST

Hand grip strength

Used to assess sarcopenia

DIAGNOSTIC_TEST

Timed Up and Go test

Screening test for falls in elderly

DIAGNOSTIC_TEST

Gait speed

Assessment to check for functional mobility and risk of falls.

DIAGNOSTIC_TEST

Clinical Frailty Scale (CFS)

Used to assess level of frailty.

Sponsors & Collaborators

  • Medway NHS Foundation Trust

    lead OTHER

Principal Investigators

  • Kamaldeep K Sahota, Pharmacist · Medway NHS Foundation Trust

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-30
Primary Completion
2026-03-31
Completion
2026-07-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07127692 on ClinicalTrials.gov